Difference between revisions of "Part:BBa K4815006"

PYPH7 targets at s. cerevisiae (saccharomyces cerevisiae), the most studied eukaryotic expression system in synthetic biology.

Loci

PYPH7 consists of two parts: the core promoter and the scaffold. The core promoter is an 80 bp sequence and is seated at approximately -170 to -90 upstream to the codon (which is the presumed transcription start site-TSS and is where most transcription factors binding sites lie). The scaffold is a preserved sequence in all PYPHs. It is a structure that we learned and utilized from previous research that can link the core promoter with the codon and provide restriction sites of BamH I and Xho I which make it possible for the plasmids with the scaffold to be inserted by various core promoter sequences at ease.

Usage and Biology

To begin with, PYPH7 can drive extremely high expression of downstream products as is predicted by our excellent AI model Pymaker. Furthermore, our experiments have abundantly validated the ability of PYPH7. Under same circumstance, PYPH7 can drive expression rate 2 times that of natural high promoters (pTEF, pGAP, pADH), which are now most widely used high expression constitutive promoters in entrepreneurship. Meanwhile, our experiments proof that this ability of driving extremely high expression is preserved among different downstream products, which make PYPH7 an excellent and practical substitute for natural promoters.

Besides, PYPH7 is anti-mutant as our excellent AI model predicts (as is represented by the red line labeled 'high' in the figure bellow). Our AI model Pymaker outperforms competitors on all sample size datasets, and its ability to predict the specific expression rate of the core promoters is proved by experiments. On this basis, we are very confident that by introducing 1-3 random mutations per generation and imitating 100 generations, those promoters, whose expression rates predicted by Pymaker remain extremely high, are highly anti-mutant. This character of anti-mutant makes PYPH7 a highly competitive merchant among promoter parts used in yeasts fermentation.

What’s more, PYPH7 shows a highly constant expression rate among yeast population, which is not the case considering the natural promoters. This character of PYPH7 is totally out of expectation but is of vital importance in yeasts fermentation on a large commercial scale.

Sequence and Features

Experiments

Extraction

We design to extract promoter sequences from synthesized whole dual-fluorescence reporter plasmids, and then insert them into the LTB-eGFP expression plasmids.We extract PYPH1-7 from our dual-fluorescence reporter plasmids, using colony PCR with designed primers (primers sequences are shown in the figure below, and spacer H1-7 stands for PYPH1-7)

Validation

We synthesized the dual-fluorescence reporter plasmids where PYPH7 is already placed in, comparing to the natural promoter GAP. We transform the plasmids into targeted yeasts and use fluorescence-activated cell sorting (FACS) strategy and record the fluorescence density through a flow cytometer. The figure above shows the result.

Proof In different scenario

PYPH 1 has shown its ability in tackling real challenges. Currently, significant breakthroughs have been achieved in the application of brewing yeast in the field of biotechnology. One of them is the production of the heat-labile toxin B subunit (LTB) of Escherichia coli using brewing yeast, an important oral vaccine adjuvant widely used to prevent various diseases such as cholera, traveler’s diarrhea, and E. coli infection. We use the same plasmid framework of BBa_K4815011 and change the YeGFP with our part BBa_K4815010, aimed at using PYPH7 to drive the expression of fusion protein LTB-eGFP. We test the expression rate from three different dimensions: flow cytometry, protein density through western blot, transcription accumulation through quantitative RT PCR, and the results are as follows.

Also, the flow cytometry result suits the result above, expression rate of LTB-eGFP driven by PYPH7 remain the sharp waveform, which means the ability to drive constant expression even better than natural constitutive promoters of PYPH7 remains when the downstream codon changes.